EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
about
Pulmonary capillary hemangiomatosis: a focus on the EIF2AK4 mutation in onset and pathogenesisThe genetics of pulmonary arterial hypertensionTransfer RNA and human diseaseUpdate in pulmonary vascular diseases 2013.Pulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USACharacteristics of patients with pulmonary venoocclusive disease awaiting transplantation.ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease.A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis.Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension.EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literatureThe genetic basis of pulmonary arterial hypertension.Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.ATS Core Curriculum 2016. Part IV. Adult Pulmonary Medicine Core Curriculum.Pulmonary veno-occlusive disease: Two children with gradual disease progression.Pulmonary capillary hemangiomatosis in a neonate with congenital diaphragmatic hernia.Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing.Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.Autopsy Findings in A Case of Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension.Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg.A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies.Mouse Genome-Wide Association Study of Preclinical Group II Pulmonary Hypertension Identifies Epidermal Growth Factor Receptor.A Semiconductor Chip-Based Next Generation Sequencing Procedure for the Main Pulmonary Hypertension Genes.Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.The integrated stress response regulates BMP signalling through effects on translation.Infantile pulmonary capillary haemangiomatosis: a lethal form of pulmonary hypertension.Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.Using Omics to Understand and Treat Pulmonary Vascular Disease.
P2860
Q26795562-D2E1E0E6-CBAB-488B-8181-7734636A7402Q27027507-725B4541-5185-456A-89C1-5FCBAA207636Q33703946-4E6DE7D3-59F7-49CF-BE8A-16FBBAA98AA2Q33732209-9F005924-2586-4D7E-AB21-21BC8FA50417Q33788468-4B3CCE71-FAC3-46FD-8146-E4C9ED424A0AQ33807374-2D5962DB-908C-4129-AB77-49E2E71B915CQ34276113-D2353BE6-CE60-4B60-814E-15512EBC7D39Q35805104-B2220071-5371-4BBC-9551-B42C3EF69497Q36016478-18120FD5-1CB3-4ED7-8E34-FB0AB4856133Q36769101-2287A9D2-90C7-4563-A4CF-A809D38DF801Q37394425-E6C1AE05-3909-4792-8332-E0FEC4C1C37BQ37605963-DEE9B35A-AD0C-45B7-AC13-2F1DC1B49972Q38179984-2FE29B69-09D9-4F71-9DE7-604C7FE64160Q38450447-E15A5F01-A6BC-4935-8BF3-9762918BC8DDQ40621949-D8FE8BAB-0314-424B-9F93-7B1CCD736156Q40945854-E0395905-FA51-42C8-9975-AB9E05D9374EQ41485401-0C944C77-1930-4CB7-97B2-7A7383CD1803Q42948676-C9D73762-357A-40EC-93D2-C12F09783061Q47108856-FF439B8B-AED5-456A-B7D0-3DD545A5999BQ47232446-2D9D3F8E-439F-47F0-969D-F7F5C12B504BQ47253821-0BD22CC8-B7B1-4917-8AE1-4456B312FB5FQ50098235-7392B168-84EA-4AEB-82DE-BA8B9546898CQ50455228-1FCDEA46-BEC6-487F-A3A4-69A6EDD829C1Q51192671-3AB3B587-D56F-4079-8161-1D8489D40029Q51494242-2088CDDC-E9D4-49DD-BB28-EB1F67C25B97Q52590989-B2180196-0312-4CBE-AE46-E3E760DEB9FAQ52612469-28900863-22F1-48BE-8625-B0626A3F0EBCQ53426536-D5E029A6-3809-4820-B6AF-BE2E5C58A43FQ55001904-1C5E7DA4-A222-4E0C-8930-1B49155E769FQ55286414-808E3E3B-A967-432C-B89E-A62C89824B48
P2860
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
@en
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
@nl
type
label
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
@en
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
@nl
prefLabel
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
@en
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
@nl
P2093
P2860
P356
P1433
P1476
EIF2AK4 mutations in pulmonary capillary hemangiomatosis.
@en
P2093
Alain C Borczuk
Anna R Hemnes
Barbara C Cahill
C Gregory Elliott
D Hunter Best
Eric D Austin
Henry D Tazelaar
Ivan M Robbins
Kelli L Sumner
Kevin O Leslie
P2860
P304
P356
10.1378/CHEST.13-2366
P407
P577
2014-02-01T00:00:00Z